A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib
Study sponsor: Zai Lab (Shanghai) Co., Ltd.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-07-20Actual
Enrollment · participants108Actual
Source updated2026-04-03Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.